MyBody-X offers DNA and microbiome tests that may provide insights relevant to menopause. For example, CLOCK gene variants can influence sleep and weight changes common in menopause; MAOA variants may relate to mood regulation; PCSK9 variants to cholesterol metabolism. The microbiome test measures gut bacterial diversity, which can be affected by hormonal shifts. However, the evidence for actionable recommendations from these tests in menopause is limited (mostly observational studies, marketing claims). These tests do not diagnose menopause or replace clinical hormone testing. MyBody-X itself does not provide menopause-specific guidance; the raw data should be interpreted cautiously and with professional support.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-5e6ecd471581717a6a8836e0